Neylan John F. 4
4 · Angion Biomedica Corp. · Filed May 19, 2021
Insider Transaction Report
Form 4
Neylan John F.
See Remarks
Transactions
- Sale
Common Stock
2021-05-18$13.91/sh−363$5,049→ 37,729 total
Footnotes (1)
- [F1]The shares reported in this Form 4 were sold pursuant to a 10b5-1 trading plan adopted by the reporting person solely to satisfy tax or other government withholding obligations in connection with the vesting of Restricted Stock Awards ("RSAs") granted by the Issuer.